HCA vs LUNG · P/E 17, rev $75.60B vs rev $83.8M
HCA Holdings Inc (HCA) versus Pulmonx Corp (LUNG) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Latest reported LUNG revenue for 2024-12-31 was $83.8M. Net income was -$56.4M. Revenue was up 22.0% from 2023-12-31 to 2024-12-31. LUNG currently screens at market cap $111.9M.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. LUNG currently screens at market cap $111.9M.
Not investment advice. Open the HCA and LUNG stock pages for the full models.
Not investment advice.